Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0XE5L
|
||||
| Former ID |
DIB005132
|
||||
| Drug Name |
Rispenzepine
|
||||
| Synonyms |
Nuvenzepine; DF-545
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] | Discontinued in Phase 2 | [545564] | ||
| Company |
Merck & Co Inc
|
||||
| Formula |
C19H20N4O2
|
||||
| Canonical SMILES |
n1(c2c(c(=O)[nH]c3c1cccc3)cccn2)C(=O)C1CN(CCC1)C
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Muscarinic acetylcholine receptor M1 | Target Info | Antagonist | [537849] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.